Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia

Juvenile myelomonocytic leukemia is a rare myeloproliferative disease in young children. While hematopoietic stem cell transplantation remains the only curative therapeutic option for most patients, children with juvenile myelomonocytic leukemia increasingly receive novel agents in phase I–II clinic...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Haematologica
Main Authors: Niemeyer, Charlotte M., Loh, Mignon L., Cseh, Annamaria, Cooper, Todd, Dvorak, Christopher C., Chan, Rebecca, Xicoy, Blanca, Germing, Ulrich, Kojima, Seiji, Manabe, Atsushi, Dworzak, Michael, De Moerloose, Barbara, Starý, Jan, Smith, Owen P., Masetti, Riccardo, Catala, Albert, Bergstraesser, Eva, Ussowicz, Marek, Fabri, Oskana, Baruchel, André, Cavé, Hélène, Zwaan, Michel, Locatelli, Franco, Hasle, Henrik, van den Heuvel-Eibrink, Marry M., Flotho, Christian, Yoshimi, Ayami
Format: Artigo
Sprog:Inglês
Udgivet: Ferrata Storti Foundation 2015
Fag:
Guideline Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4281308/
https://ncbi.nlm.nih.gov/pubmed/25552679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.109892
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker